Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$2.39 - $6.02 $37,735 - $95,049
-15,789 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$5.36 - $7.99 $103,549 - $154,358
-19,319 Reduced 55.03%
15,789 $86,000
Q2 2021

Aug 12, 2021

BUY
$5.82 - $8.72 $133,499 - $200,019
22,938 Added 188.48%
35,108 $261,000
Q1 2021

May 13, 2021

BUY
$7.2 - $16.82 $87,624 - $204,699
12,170 New
12,170 $99,000

Others Institutions Holding KLDO

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.